Published online Apr 27, 2026. doi: 10.4254/wjh.v18.i4.117993
Revised: January 19, 2026
Accepted: February 13, 2026
Published online: April 27, 2026
Processing time: 122 Days and 3.4 Hours
The transmembrane activator and calcium-modulator and cyclophilin ligand interactor, encoded by tumor necrosis factor receptor superfamily member 13B (TNFRSF13B), maintains immune homeostasis through bidirectional regulation of B-cell function. This study presents a case of a 56-year-old female with chronic cholangitis and cirrhosis associated with a heterozygous missense mutation in TNFRSF13B.
A 56-year-old female with thalassemia trait and recurrent ascending cholangitis following cholangiojejunostomy presented with cirrhosis of unclear etiology. Despite serial hospitalizations for cholestatic decompensation and comprehensive evaluations-including serological profiling with elevated antinuclear antibody titers and histopathological assessment-no conventional cirrhosis triggers were identified. The patient presented with elevated serum immunoglobulin A (IgA) and IgG, and no apparent immune dysfunction. Two magnetic resonance imaging examinations revealed absence of the left hepatic lobe and gallbladder, no dilation of in
TNFRSF13B mutation may impair B-cell negative regulation, promoting cholangitis, and cirrhosis. Iron overload and bacterial infection accelerate disease progression.
Core Tip: Tumor necrosis factor receptor superfamily member 13B (TNFRSF13B) maintains immune homeostasis through bidirectional regulation of B cell function. This case report presents a case where a TNFRSF13B mutation that may impair TACI’s negative regulatory control over B cell activity, causing B cell hyperactivation, sustained local inflammatory responses, and chronic cholangitis progressing to cirrhosis. This finding provides a novel immunogenetic perspective for understanding certain autoimmune liver diseases of unknown etiology.
